A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Clinical trial NCT07219615 · RECRUITING
Trial details
- NCT number
- NCT07219615
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-30
- Primary completion
- 2026-12-25
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.